Literature DB >> 26056180

YAPing Hippo Forecasts a New Target for Lung Cancer Prevention and Treatment.

Duojia Pan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26056180      PMCID： PMC4811021          DOI： 10.1200/JCO.2015.61.2093

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  34 in total

1.  Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma.

Authors:  Antoine M Snijders; Brian L Schmidt; Jane Fridlyand; Nusi Dekker; Daniel Pinkel; Richard C K Jordan; Donna G Albertson
Journal:  Oncogene       Date:  2005-06-16       Impact factor: 9.867

Review 2.  From cell structure to transcription: Hippo forges a new path.

Authors:  Bruce A Edgar
Journal:  Cell       Date:  2006-01-27       Impact factor: 41.582

3.  The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis.

Authors:  Fisun Hamaratoglu; Maria Willecke; Madhuri Kango-Singh; Riitta Nolo; Eric Hyun; Chunyao Tao; Hamed Jafar-Nejad; Georg Halder
Journal:  Nat Cell Biol       Date:  2005-12-11       Impact factor: 28.824

4.  Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.

Authors:  Zheng Jiang; Xingang Li; Jin Hu; Wei Zhou; Yuquan Jiang; Gang Li; Daru Lu
Journal:  Neurosci Res       Date:  2006-10-17       Impact factor: 3.304

Review 5.  Hippo signaling in organ size control.

Authors:  Duojia Pan
Journal:  Genes Dev       Date:  2007-04-15       Impact factor: 11.361

6.  Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP.

Authors:  Yi Liu-Chittenden; Bo Huang; Joong Sup Shim; Qian Chen; Se-Jin Lee; Robert A Anders; Jun O Liu; Duojia Pan
Journal:  Genes Dev       Date:  2012-06-07       Impact factor: 11.361

7.  Array-based comparative genomic hybridization identifies localized DNA amplifications and homozygous deletions in pancreatic cancer.

Authors:  Murali D Bashyam; Ryan Bair; Young H Kim; Pei Wang; Tina Hernandez-Boussard; Collins A Karikari; Robert Tibshirani; Anirban Maitra; Jonathan R Pollack
Journal:  Neoplasia       Date:  2005-06       Impact factor: 5.715

8.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

9.  Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.

Authors:  Dawang Zhou; Claudius Conrad; Fan Xia; Ji-Sun Park; Bernhard Payer; Yi Yin; Gregory Y Lauwers; Wolfgang Thasler; Jeannie T Lee; Joseph Avruch; Nabeel Bardeesy
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

10.  The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals.

Authors:  Nailing Zhang; Haibo Bai; Karen K David; Jixin Dong; Yonggang Zheng; Jing Cai; Marco Giovannini; Pentao Liu; Robert A Anders; Duojia Pan
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270
View more
  8 in total

Review 1.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

2.  Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.

Authors:  Hongbin Li; Barry M Gumbiner
Journal:  Mamm Genome       Date:  2016-09-06       Impact factor: 2.957

3.  Hippo signaling promotes JNK-dependent cell migration.

Authors:  Xianjue Ma; Hongxiang Wang; Jiansong Ji; Wenyan Xu; Yihao Sun; Wenzhe Li; Xiaoping Zhang; Juxiang Chen; Lei Xue
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

4.  Small cell lung cancer tumors and preclinical models display heterogeneity of neuroendocrine phenotypes.

Authors:  Wei Zhang; Luc Girard; Yu-An Zhang; Tomohiro Haruki; Mahboubeh Papari-Zareei; Victor Stastny; Hans K Ghayee; Karel Pacak; Trudy G Oliver; John D Minna; Adi F Gazdar
Journal:  Transl Lung Cancer Res       Date:  2018-02

5.  Integrin signalling regulates YAP and TAZ to control skin homeostasis.

Authors:  Ahmed Elbediwy; Zoé I Vincent-Mistiaen; Bradley Spencer-Dene; Richard K Stone; Stefan Boeing; Stefanie K Wculek; Julia Cordero; Ee H Tan; Rachel Ridgway; Val G Brunton; Erik Sahai; Holger Gerhardt; Axel Behrens; Ilaria Malanchi; Owen J Sansom; Barry J Thompson
Journal:  Development       Date:  2016-03-17       Impact factor: 6.868

6.  Repression of YAP by NCTD disrupts NSCLC progression.

Authors:  Jiwei Guo; Yan Wu; Lijuan Yang; Jing Du; Kaikai Gong; Weiwei Chen; Juanjuan Dai; XueLin Li; Sichuan Xi
Journal:  Oncotarget       Date:  2017-01-10

7.  Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.

Authors:  Yao Zhang; Ye Hu; Jing-Yuan Fang; Jie Xu
Journal:  Oncotarget       Date:  2016-03-08

Review 8.  [Molecular Mechanism of Different Signaling Pathways in Regulating PD-L1 Expression in EGFR Mutated Lung Adenocarcinoma].

Authors:  Xuefeng Leng; Jiandong Mei; Lunxu Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.